CDMO Avid BioservicesWatchlist
Avid Bioservices News
Uber Technologies, Jabil and Builders FirstSource Set to Join S&P 500; Others to Join S&P MidCap...
Avid Bioservices to Report Financial Results for Second Quarter of Fiscal Year 2024 After Market Close on December 7, 2023
Avid Bioservices (CDMO) Moves 9.0% Higher: Will This Strength Last?
Further Weakness as Avid Bioservices (NASDAQ:CDMO) Drops 19% This Week, Taking One-year Losses to 66%
Even the best stock pickers will make plenty of bad investments. And there's no doubt that Avid Bioservices, Inc. (NASDAQ:CDMO) stock has had a really bad year. In that relatively short period, the
Craig-Hallum Sticks to Its Buy Rating for Avid Bioservices (CDMO)
Avid Bioservices Partners With California Institute for Regenerative Medicine (CIRM) to Provide CDMO Services for Cell and Gene Therapy (CGT) Programs
TUSTIN, Calif., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by providing
IQVIA Holdings Cuts 2023 Guidance Hurting Rivals
Does Avid Bioservices (CDMO) Have Potential For 200-400% Returns Over the Next Few Years?
Eli Lilly Said to Have Hired CDMO CordenPharma for Mounjaro API
Avid Bioservices Completes Construction of New, World-Class Cell and Gene Therapy Development and Manufacturing Facility
Newly Launched CGMP Manufacturing Suites Undergoing Final Environmental Monitoring and Performance Qualification with Grand Opening Planned for January 2024 Completion of CGT Facility Brings Company's Total Revenue
Calculating The Intrinsic Value Of Avid Bioservices, Inc. (NASDAQ:CDMO)
William Blair Initiates Coverage on Avid Bioservices With Market Perform Rating
Avid Bioservices (CDMO) has an average buy rating and price target range of $15 to $22, according to analysts polled by Capital IQ.
Avid Bioservices to Participate in RBC Capital Markets Virtual CDMO Conference
Insider Spends US$191k Buying More Shares In Avid Bioservices
Investors who take an interest in Avid Bioservices, Inc. (NASDAQ:CDMO) should definitely note that the Independent Chairman, Joseph Carleone, recently paid US$9.53 per share to buy US$191k worth of th
Insider Buying: Director Joseph Carleone Acquires 20,000 Shares of Avid Bioservices Inc (CDMO)
Avid Bioservices Insider Bought Shares Worth $190,696, According to a Recent SEC Filing
Joseph Carleone, Director, on September 21, 2023, executed a purchase for 20,000 shares in Avid Bioservices (CDMO) for $190,696. Following the Form 4 filing with the SEC, Carleone has control over a t
Stocks That Hit 52-Week Lows On Thursday
During the session on Thursday, 461 stocks hit new 52-week lows. Noteworthy Points From Today's 52-Week Lows: The largest company in terms of market cap to set a new 52-week low was Pfizer (NYSE:PFE
Avid Bioservices (NASDAQ:CDMO) Is Making Moderate Use Of Debt
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the permanent loss of capital.' It's only natural to consider a company's balance sheet wh
US stocks closed | The three major indices closed slightly higher, chip stocks and Chinese securities generally fell, Nvidia fell for three days in a row, and Station B fell more than 5%
The NASDAQ stopped four consecutive declines, and the S&P ended this week with two weeks of continuous gains. Apple fell nearly 6% in a week, chip stocks and China stock indexes outperformed the market for several days. Nvidia fell more than 1%, fell more than 6% throughout the week, and Qualcomm fell 8% in a week.
Stocks That Hit 52-Week Lows On Friday
Friday's session saw 225 companies set new 52-week lows. Significant Points From Today's 52-Week Lows: Norfolk Southern (NYSE:NSC) was the largest, in terms of market cap, to set a new 52-week low.G